RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ACADIA Pharmaceuticals Stock

ACADIA Pharmaceuticals P/S 2024

ACADIA Pharmaceuticals P/S

2.58

Ticker

ACAD

ISIN

US0042251084

WKN

603035

As of Oct 21, 2024, ACADIA Pharmaceuticals's P/S ratio stood at 2.58, a -52.13% change from the 5.39 P/S ratio recorded in the previous year.

The ACADIA Pharmaceuticals P/S history

ACADIA Pharmaceuticals Aktienanalyse

What does ACADIA Pharmaceuticals do?

ACADIA Pharmaceuticals Inc is a biopharmaceutical company based in San Diego, California. The company was founded in 1993 and specializes in the development and commercialization of medications for neurological disorders. ACADIA Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding ACADIA Pharmaceuticals's P/S Ratio

ACADIA Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing ACADIA Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating ACADIA Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in ACADIA Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about ACADIA Pharmaceuticals stock

What is the price-to-earnings ratio of ACADIA Pharmaceuticals?

The price-earnings ratio of ACADIA Pharmaceuticals is currently 2.58.

How has the price-earnings ratio of ACADIA Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of ACADIA Pharmaceuticals has increased by -52.13% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of ACADIA Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of ACADIA Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of ACADIA Pharmaceuticals affect the company?

An increase in the price-earnings ratio of ACADIA Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of ACADIA Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of ACADIA Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of ACADIA Pharmaceuticals?

Some factors that influence the price-earnings ratio of ACADIA Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does ACADIA Pharmaceuticals pay?

Over the past 12 months, ACADIA Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ACADIA Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of ACADIA Pharmaceuticals?

The current dividend yield of ACADIA Pharmaceuticals is .

When does ACADIA Pharmaceuticals pay dividends?

ACADIA Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of ACADIA Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ACADIA Pharmaceuticals located?

ACADIA Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von ACADIA Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ACADIA Pharmaceuticals from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did ACADIA Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of ACADIA Pharmaceuticals in the year 2023?

In the year 2023, ACADIA Pharmaceuticals distributed 0 USD as dividends.

In which currency does ACADIA Pharmaceuticals pay out the dividend?

The dividends of ACADIA Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ACADIA Pharmaceuticals

Our stock analysis for ACADIA Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ACADIA Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.